- Home
- SMTI vs VYGR Comparison
SMTI vs VYGR Comparison
Compare SMTI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- VYGR
- Stock Information
- Founded
- SMTI 1982
- VYGR 2013
- Country
- SMTI United States
- VYGR United States
- Employees
- SMTI N/A
- VYGR N/A
- Industry
- SMTI Medical/Dental Instruments
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- VYGR Health Care
- Exchange
- SMTI Nasdaq
- VYGR Nasdaq
- Market Cap
- SMTI 288.2M
- VYGR 309.7M
- IPO Year
- SMTI N/A
- VYGR 2015
- Fundamental
- Price
- SMTI $36.64
- VYGR $6.45
- Analyst Decision
- SMTI Buy
- VYGR Strong Buy
- Analyst Count
- SMTI 1
- VYGR 9
- Target Price
- SMTI $44.00
- VYGR $16.44
- AVG Volume (30 Days)
- SMTI 35.0K
- VYGR 570.6K
- Earning Date
- SMTI 11-12-2024
- VYGR 11-12-2024
- Dividend Yield
- SMTI N/A
- VYGR N/A
- EPS Growth
- SMTI N/A
- VYGR N/A
- EPS
- SMTI N/A
- VYGR 0.47
- Revenue
- SMTI $78,056,873.00
- VYGR $163,784,000.00
- Revenue This Year
- SMTI $29.95
- VYGR N/A
- Revenue Next Year
- SMTI $19.68
- VYGR N/A
- P/E Ratio
- SMTI N/A
- VYGR $13.83
- Revenue Growth
- SMTI 24.66
- VYGR 3.40
- 52 Week Low
- SMTI $26.00
- VYGR $5.19
- 52 Week High
- SMTI $43.25
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- SMTI 56.60
- VYGR 51.85
- Support Level
- SMTI $34.50
- VYGR $6.13
- Resistance Level
- SMTI $37.60
- VYGR $7.44
- Average True Range (ATR)
- SMTI 1.88
- VYGR 0.34
- MACD
- SMTI -0.23
- VYGR 0.09
- Stochastic Oscillator
- SMTI 59.81
- VYGR 56.00
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.